The GiveWell Blog

A promising study re: Development Media International

Development Media International (DMI), an organization that “runs radio and TV campaigns to change behaviours and save lives in developing countries,” recently released preliminary midline results from a randomized controlled trial. These results imply that exposure to DMI’s content caused people to take up a variety of behaviors (including early initiation of breastfeeding and various measures for controlling diarrhea) at increased rates. We have not yet seen the full technical report and we have substantial questions about these results, but believe that the basic design of the study is a major improvement on previous evidence regarding similar programs.

If the results – and DMI’s cost-effectiveness calculations – held up, DMI could become a GiveWell top charity with substantially better estimated “cost per (equivalent) life saved” than our current top charities. Because of the nature of DMI’s intervention – attempting to change behavior through mass media – it is quite plausible to us that its cost per person reached is extremely small, and thus that the cost-effectiveness is extremely high. However, there are many questions we would need to look into before determining whether this is in fact the case.

As such, we plan to investigate DMI thoroughly this year. There is some possibility that we will decide to recommend it at the end of this calendar year, and some possibility that we will instead choose to hold off on deciding whether to recommend it until next year, when the study’s endline results (which we expect to give a more reliable picture of its impact) are released. Note that we recommend only charities that we have thoroughly vetted and spent substantial time considering alongside other contenders, and we have designed our process to be most up-to-date when it is most relevant (in December); so regardless of what we find, we are extremely unlikely to change any official recommendations ahead of that timeline. Our recommendations do not reflect real-time “best guesses,” but rather reflect the results of thorough investigation and deliberation.

More on DMI and the recent study results
We’ve long been interested in mass media for behavior change: aiming to use mass media (e.g., radio or television programming, often soap operas) to promote and disseminate messages on potential life-saving practices such as oral rehydration therapy, sleeping under bednets, breastfeeding, etc. It’s quite plausible to us that messages on TV or the radio could influence behavior, and could reach massive numbers of people for relatively low costs, leading to high cost-effectiveness in terms of lives saved or improved per dollar spent.

However, as we state in our current writeup on the subject, we have previously found research on such programs to have important limitations and to be generally prone to selection bias. As such, we have been keeping tabs on DMI’s ongoing study, which – unlike previous work – uses randomization to isolate the impacts of its programming.

Preliminary, public discussion of DMI’s midline results became available recently, and we conducted a conversation with DMI representatives about the results (notes from this conversation are forthcoming). We note that:

  • The preliminary results seem to indicate that DMI’s intervention had substantial impacts on behavior change (the easiest way to see this is to scan the rightmost column, “differences in differences (unadjusted)” in DMI’s table, though there is some other evidence available as well). We do not yet have complete information about the statistical significance of these findings (the public report gives p-values for four of ten behaviors).
  • It appears that the treatment and control groups differed substantially at baseline (in terms of their behaviors and other indicators), making the comparison less than ideal. In addition, the control group (which did not receive DMI’s intervention) saw substantial improvement on the key indicators, which we don’t have an explanation for at this time. With that said, skimming the summary table provided by DMI, it appears that in many cases, the treatment group started with lower rates of a given behavior, and then caught or surpassed the control group, which (when viewed in the context of a randomized selection process) does seem to indicate a positive effect to us, though the magnitude may prove hard to estimate reliably.
  • DMI provides an estimate that its intervention costs ~$60-300 per life saved, which would make it much stronger (around an order of magnitude stronger) than the strongest of our top charities. DMI also stated to us in conversation that the midline results are reasonably consistent with the assumptions that went into the estimate, though it appears to us that there will be substantial judgment calls in how to interpret the results in light of the estimate. We have not yet seen the technical details of DMI’s estimate. We expect our final estimate of DMI’s “cost per life saved” to be substantially less optimistic than DMI’s current estimate, but at this time it is hard to say by how much.
  • DMI’s midline results come entirely from self-reported data on behavior, which is potentially a highly problematic measure for assessing the impact of a mass media campaign (since the media campaign may impact people’s perceptions of how they should respond to surveys more than it affects their actual behavior). It appears to us that DMI is aware of this issue, and states that its endline results (slated for 2015) will measure mortality.
  • Based on DMI’s website and our discussion, we preliminarily perceive DMI so far to be unusually thoughtful and analytical in its self-evaluation and -analysis.

Our next steps
We hope to:

  • Obtain the technical report behind the midline results and examine it closely. DMI has offered to share this with us in the next few weeks.
  • Examine the technical details behind DMI’s “cost per life saved” estimate and assess them with our analysis of the midline results in mind. DMI has shared its model with us, though we have not yet examined it.
  • Get more information about DMI’s plans and room for more funding and consider how our cost-effectiveness estimate might change in light of these.
  • If warranted, further examine DMI via a site visit and create a full charity review.

Because of the strong study design, the degree of thoughtfulness and analysis we’ve seen so far from DMI, and the strong claimed cost-effectiveness and basic plausibility of the claim, we believe there is a substantial chance that DMI will eventually become a recommended charity, and that there is also a (smaller) chance that we will end up estimating substantially higher “bang for the buck” for DMI compared to our current top charities. If this turns out to be the case, we will hope to help close any funding gap of DMI’s.

Finding giving opportunities in malaria control/elimination

[Added August 27, 2014: GiveWell Labs is now known as the Open Philanthropy Project.]

As part of our work on GiveWell Labs, we retained Dr. Steven Phillips as a consultant to source giving opportunities in malaria control/elimination.

This post lays out:

  • The work that Dr. Phillips did for us in order to source giving opportunities. More
  • Why we undertook this project in partnership with Dr. Phillips. We are not currently moving forward with the giving opportunities sourced; this is a function not of the quality of the opportunities (many of which appear potentially strong to us) but of how our strategic priorities have evolved. More
  • What we learned from this project about giving opportunities in this area, as well as about the practice of sourcing giving opportunities more generally. More
  • Brief summaries of the giving opportunities. More

About Dr. Phillips: Dr. Phillips serves or has served on the Boards and Advisory bodies of the following organizations: Malaria No More, Net Impact, the World Economic Forum’s Global Health Advisory Board, advisor to the United Nations Special Envoy for Malaria, the Harvard School of Public Health’s Leadership Council and the advisory panels of Medicines for Malaria Ventures, the UCSF Global Health Group, Episcopal Relief and Development’s “NetsforLife” Initiative, the World Bank Malaria Booster Program, the Strategic Advisory Group of the Global Business Coalition on HIV/AIDS, TB and Malaria, the World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR) Strategic Alliances Advisory Group. He was also a Private Sector Advisory Board representative to the Global Fund for AIDS, TB and Malaria, and a private sector representative on the board of Roll Back Malaria.


The project
Before he began this project, Dr. Phillips categorized giving opportunities in malaria as (a) research and development of new drugs, vaccines and technologies, (b) program delivery or operations research, and (c) advocacy to increase awareness of and funding directed to malaria. We agreed with Dr. Phillips to focus his work on (b), program delivery and operations research.

Dr. Phillips communicated with many prominent organizations (e.g., President’s Malaria Initiative, Center for Disease Control, Population Services International, Malaria no More among others) that focus on malaria asking for giving opportunities. We agreed with Dr. Phillips that Good Ventures would consider providing funding to the opportunities, depending on their fit with our broader priorities in GiveWell Labs.


Why we worked on this
We decided to undertake this project because:

  • As of September 2013 (when we began this project), we felt that deeply investigating a cause and likely making some grants within it was necessary in order to learn. At that point, malaria control was one of the top contenders for a cause we would focus on and make grants in. (More in our September 2013 GiveWell Labs update.) Since then, we have begun grantmaking in labor mobility and criminal justice reform (two of the other causes mentioned in that post). At the same time, we have been reflecting on how best to approach causes in the broad area of “foreign aid” and as of early 2014, are still considering how best to move forward. (More in our March 2014 annual review and plan post for GiveWell Labs.)
  • Our approach to identifying giving opportunities is non-traditional and we sought the experience of someone like Dr. Phillips, who has significant experience working (a) on malaria programming, (b) grantmaking/identifying giving opportunities, and (c) malaria in the broader context of global health and international development assistance. In addition to the interest in malaria specifically, we also hoped to improve our understanding of the process of finding giving opportunities.

We felt that we learned important things on both of the above points (more below).

Ultimately, we decided not to move forward with funding the opportunities Dr. Phillips identified. This is not a function of the quality of the ideas Dr. Phillips received, but is due the fact that we’re not yet at a point where we are prepared to commit significant funding and staff time to malaria (more in our recent review and plan for GiveWell Labs). We plan to revisit these proposals if and when we choose to commit more thoroughly to this area.


What we learned
Dr. Phillips advised us not to ask participating organizations to publish the full details of the ideas they proposed; instead, we summarize the key things we learned below.

  • This project successfully sourced promising giving opportunities. Were we to have decided to commence grantmaking in malaria, we likely would have moved forward with a number of these projects. Had we tried to source these giving opportunities on our own, we would likely have struggled to do so (or spent an unreasonable amount of time trying to do so); because of Dr. Phillips’s subject-matter knowledge and relationships with people in the sector, he was able to source giving opportunities relatively easily, requiring limited time investment from GiveWell staff. In the future, we may undertake a similar process for causes in which we are aiming to make grants.
  • Unrelated to Dr. Phillips’s project, we have been investigating the hypothesis that data is underinvested in in the malaria sector (one set of conversation notes here, more forthcoming). We formed this theory based on our top charities work and our impressions that there is a lack of information available regarding questions such as (a) how long do LLINs last in the field; (b) what are the impacts of insecticide resistance on LLIN-effectiveness; and (c) to what extent does covering a proportion of a community (e.g., 50%) with LLINs confer protective benefits to the entire area, among others. Dr. Phillips was acting independently of this internal research project; nevertheless, half of the ideas he received (14/27) focused on data (10) or evaluation (4), which we take as some support for our hypothesis.
  • Four of the ideas proposed to Dr. Phillips could be considered as part of GiveWell’s traditional work on finding and recommending top charities. We intend to add these to our list of opportunities to consider in the future.

We also continued to experience the challenge of working in a field (philanthropy) where limited information is publicly available. Ideally, we’d like to have 20+ proposals for each cause we’d consider committing to (as we now do for malaria delivery and operational research) and use those proposals as a major input into the causes we would ultimately choose. Unfortunately, this data set does not exist and we don’t believe it’s feasible to create it.

It seems to us that organizations are happy to engage with a funder when funding is reasonably likely to result (as it was in the case of this project) but would be less likely to do so as the odds of receiving funding fell. Were we to try to solicit proposals across the spectrum of foreign aid, that would likely require many projects of the type Dr. Phillips conducted, and we don’t believe organizations would be willing to participate in our process given the low probability that they would receive funding.


Proposal summaries
We are not publishing the full details of each proposal we received. Instead, we post brief summaries of each proposal, without the name of the organization that proposed it, and our categorization of the project.

We include proposals only from those organizations who have agreed to participate and have kept other proposals confidential.

We categorize each project as:

  • Data
  • Evaluation
  • Delivery (i.e., rolling out evidence-backed programs)
  • Elimination
  • Other

Proposal topics:

Data

  • Combining multiple data sources, including SMS authentication codes for antimalarial drugs, to map malaria prevalence and treatment.
  • Field testing a low-cost device to detect substandard and counterfeit malaria medications.
  • Developing a device for use in the field to diagnose malaria via molecular assays.
  • Research to determine why children who died from malaria did not receive effective treatment.
  • Developing a practical field diagnostic test to monitor and improve the performance of indoor residual spraying of organophosphates.
  • Developing an extension to malaria database management software used by national control programs. The extension would help the control programs synthesize and visualize the data managed by the software to inform decisions about control activities.

Evaluation

    • Evaluating service delivery mechanisms for seasonal malaria chemoprevention and advising national malaria control programs on implementing seasonal chemoprevention.
    • Evaluating the use of local materials to improve housing in order to prevent the entry of mosquitoes.
    • Randomized controlled trial to determine the safety and efficacy of a novel malaria vaccine candidate.

Delivery

    • Instituting high-quality malaria testing and treatment within a franchise of private clinics.
    • Expanding a program to work with plantations to provide malaria protection and case management to migrant plantation workers. These workers are at uniquely high risk for contracting and transmitting malaria, so providing them with malaria care is important to achieving malaria elimination.
    • Adding indoor residual spraying to a strategic package of program interventions against malaria in an African setting with high levels of malaria transmission.
    • Funding community health workers in remote villages to travel to households in order to seek out and treat malaria cases.

Elimination

  • Formalizing a partnership among Latin American and Caribbean countries to work towards malaria elimination by sharing data and coordinating control efforts.
  • Creating and supporting malaria elimination leadership teams in two countries.
  • Assembling a team of malaria field experts to provide technical assistance to a number of national malaria programs pursuing elimination.
  • Employing village health workers and engaging community leaders to achieve zero deaths from malaria and to begin working towards elimination at the community level.
  • Eliminating malaria in a small island community.

Other

  • Developing and testing a digital board game to teach villagers about malaria prevention and treatment.
  • Advocating to recipient country leaders to request that Global Fund grants target funds to malaria as opposed to HIV or TB.
  • Raising funds from the public for malaria treatment.

 

Meta-Research Innovation Center at Stanford (METRICS)

Notes on this post:

  • Stuart Buck of the Laura and John Arnold Foundation, as well as Prof. Steven Goodman of METRICS, reviewed a draft of this post. 
  • Throughout the post, “we” refers to GiveWell and Good Ventures, who work as partners on GiveWell Labs. [Added August 27, 2014: GiveWell Labs is now known as the Open Philanthropy Project.]

We’re very excited for the launch of Meta-Research Innovation Center at Stanford (METRICS), co-founded by John Ioannidis and Steven Goodman and supported by a grant from the Laura and John Arnold Foundation (LJAF). METRICS will bring together researchers to study the state of medical research quality, including questions such as how concerned we should be about publication bias (which the founders have published helpful papers on in the past), and to advocate for potential solutions. (Also see coverage in The Economist.)

Our work on GiveWell Labs was responsible for initially connecting the METRICS founders to LJAF, which is providing a commitment of up to ~$6 million to help METRICS through its initial years, during which time METRICS will be seeking more sources of support. We find it worthwhile to lay out the events that led to this connection, partly because they indicate some degree of impact on our part (though not of our usual kind) and partly because they make for an interesting case study in how to source giving opportunities.

Our role in connecting METRICS and LJAF

  • In 2012, we investigated the US Cochrane Center, in line with the then-high priority we placed on meta-research. As part of our investigation, we were connected – through our network – to Dr. Steven Goodman, who discussed Cochrane with us (notes). We also asked him about other underfunded areas in medical research, and among others he mentioned the idea of “assessing or improving the quality of evidence in the medical literature” and the idea of establishing a center for such work.
  • During our follow-up email exchange with Dr. Goodman, we mentioned that we were thinking of meta-research in general as a high priority, and sent him a link to our standing thoughts on the subject. He responded, “I didn’t know of your specific interest in meta-research and open science … Further developing the science and policy responses to challenges to the integrity of the medical literature is also the raison d’etre of the center I cursorily outlined, which is hard to describe to folks who don’t really know the area; I didn’t realize how far down that road you were.” He mentioned that he could send along a short proposal, and we said we’d like to see it.
  • At the same time, we were in informal conversations with Stuart Buck at the Laura and John Arnold Foundation (LJAF) about the general topic of meta-research. LJAF had expressed enthusiasm over the idea of the Center for Open Science (which it now supports), and generally seemed interested in the topic of reproducibility in the social sciences. I asked Stuart whether he would be interested in doing some funding related to the field of medicine as well, and in reviewing a proposal in that area that I thought looked quite promising. He said yes, and (after checking with Dr. Goodman) I sent along the proposal.
  • From that point on, LJAF followed its own process, though we stayed posted on the progress, reviewed a more fleshed-out proposal, shared our informal thoughts with LJAF, and joined (by videoconference) a meeting between LJAF staff and Drs. Ioannidis and Goodman.
  • Following the meeting with Drs. Ioannidis and Goodman, we told Stuart that we would consider providing a modest amount of co-funding (~10%) for the initial needs of METRICS. He said this wouldn’t be necessary as LJAF planned to provide the initial funding.

Takeaways
Case study in “active funding.” We’ve written before about the evolution of our thinking on active vs. passive funding. Specifically, while we used to imagine reviewing a large number of project proposals and recommending the best for funding, we now take the approach of choosing “causes” – broad areas/problems of interest, even when it isn’t obvious what the interventions or grantees would be – and looking for giving opportunities only after we’ve identified causes to focus on. Part of the reasoning behind this approach is that project proposals often emerge in response to funder interests, so it’s may not be possible to find all the possible projects to fund in an area until one starts actively expressing interest in the area.

The above case is a good example of this. The conversations we had with LJAF and with Dr. Goodman sprang out of a pre-declared interest in the cause of meta-research, and in Dr. Goodman’s case it seems he would never have sent the proposal if not for our clearly articulated interest in the subject.

Our impact. GiveWell never issued an official recommendation in favor of funding METRICS. While we shared informal opinions with LJAF, LJAF followed its own evaluation process and decided on its own to provide funding. So we don’t think the LJAF grant ought to be considered as GiveWell money moved in the usual sense. In addition, we don’t know what the counterfactual impact of our role was; it’s possible that LJAF would eventually have found and funded METRICS. With that said, it seems to us that by actively prioritizing the area of meta-research and following the lines of investigation we did, we raised the speed and probability of this project’s moving forward. On review of this post, Stuart stated “I’m certain that I wouldn’t have come across [the] initial proposal in any other way.”

Note that this post initially included a discussion of another project that we thought had had a similar dynamic. We introduced Elizabeth Iorns, founder of the Reproducibility Initiative, to Stuart Buck of LJAF in April 2013 (after a February 2013 conversation with Dr. Iorns as part of our continuing meta-research investigation); LJAF has since provided support for the Reproducibility Initiative through the Center for Open Science. However, Stuart corrected us on this point, pointing out that he was introduced to Elizabeth independently about a month after our intro; we now believe we played little to no role (relative to the counterfactual) in that connection.

Where we stand on meta-research
In mid-2013, we gave two updates on our thinking regarding meta-research: a landscape of the “open science” community and a more general update listing several things that “meta-research” could mean. We noted that we were planning to pause work on this front until we had examined some other causes.

At this time, our take is that:

  • There is more philanthropic interest in promoting reproducibility and open science (which had initially been the focus of our investigations) than we had initially guessed. (Note that LJAF became interested in these areas around the time that we did.)
  • Given the players that are already present, and having explored some other areas, our sense is that there are higher-leverage causes for us to enter.
  • We are trying to explore the broader concept behind “meta-research” – thinking about how to improve the incentives that academics face, both as they relate to reproducibility and as they relate to other matters – as part of our scientific research investigations.
  • We are extremely happy to see the launch of METRICS, which we believed to be probably the single most exciting giving opportunity we saw while exploring meta-research (and one we might have considered for a recommendation if not for LJAF’s interest).

David Roodman’s draft writeup on the mortality-fertility connection

We’re sometimes asked whether life-saving interventions (such as insecticide-treated net distribution) risk leading to overpopulation. A common response is that (as argued by Hans Rosling of Gapminder and the most recent Gates Foundation annual letter, among others) the reverse dynamic holds: population growth tends to slow as child mortality declines, possibly because parents feel less need to have multiple children in order to hedge against the risk of death.

Empirically, it appears generally true that lower child mortality tends to correlate with slower population growth. However, one might ask whether this relationship is causal (i.e., falling mortality leads to falling fertility, for reasons outlined in the previous paragraph) or merely correlational (i.e., falling mortality generally accompanies a host of factors related to general economic development, and including falling population growth). This question is important when assessing the impact of a life-saving intervention in isolation: it’s possible that health interventions, unaccompanied by improvements on other dimensions, do in fact lead to higher populations.

We’ve long wondered about this question, and we recently commissioned David Roodman – whom we have been impressed with in the past – to examine the rather extensive and complex literature on it. David has recently posted a draft of his writeup, and is seeking feedback.

We haven’t yet fully vetted the writeup, but it appears to me to give a deep and balanced examination of the available literature, along with interesting discussion of the general challenges of isolating causality in cross-country studies. Its conclusion:

I think the best interpretation of the available evidence is that the impact of life-saving interventions on fertility and population growth varies by context, above all with total fertility, and is rarely greater than 1:1 [rarely enough for the fertility decline to exceed the mortality decline in terms of effect on population size]. In places where lifetime births/woman has converging to 2 or lower, family size is largely a conscious choice, made with an ideal family size in mind, and achieved in part by access to modern contraception. In those contexts, saving one child’s life should lead parents to avert a birth they would otherwise have. The impact of mortality drops on fertility will be nearly 1:1, so population growth will hardly change.

Overall, it appears that life-saving interventions unaccompanied by other improvements, where access to contraception is weak, are likely to lead to some acceleration of population growth. With that said, we wish to note the following:

  • No intervention takes place in isolation, and we expect population growth to slow in the future in most low-income areas as poverty falls.
  • Acceleration of population growth should not necessarily be associated with overpopulation and its connotations of a net decline in standards of living.
  • GiveWell’s current top charities are all focused on improving living standards rather than averting deaths, and Against Malaria Foundation (a former and potentially future top-rated charity) aims to avert deaths and bring about other benefits by reducing the burden of malaria.

We encourage our readers to check out the writeup and send in their thoughts. It’s a thorough review of the question and a generally interesting read.

David Roodman’s draft writeup, “The impact of life-saving interventions on fertility”
 

More on why we commissioned this writeup

We have previously made some preliminary attempts to review the literature on the connection between mortality and fertility. However, we’ve found this literature to be (a) challenging to synthesize, as most of the key papers use relatively complex methodologies that would take significant work to interpret; (b) only a moderate priority for our research, since it has limited relevance to which charities we recommend and how we rank them.

Recently, we decided to explore the idea of working with David Roodman (whom we’ve generally been impressed with) as someone who might increase our capacity to produce thorough reviews of literature on key giving-relevant questions. For our first project together, we chose to work on this question because David had done substantial work on it in the past, and felt he could produce an initial writeup relatively quickly.

Our work on outreach

One of the core questions we’ve faced throughout GiveWell’s history has been whether to allocate our time to research (i.e., identifying and evaluating outstanding giving opportunities) or outreach (i.e., increasing the number of donors who are aware of GiveWell and use our research, and the amount of money we move to top charities). The question of “research vs. outreach” was one of the most common topics at board meetings in our early years, and new staff and supporters often ask us why we don’t focus more of our time on outreach.

Over the course of GiveWell’s history, we’ve taken many approaches to increase awareness of our work. We’ve tried all of these throughout our history, so we believe the experiences described below are reasonably representative of “what we’d expect to work today” rather than specific to a particular point in GiveWell’s development. The purpose of this post is to share our observations of what has worked and what hasn’t, in order to help people understand why we prioritize our time as we do and also in order to potentially help people thinking about their own outreach strategies.

The big picture is that:

  • Proactive “marketing” has contributed little to our growth.
  • Much of our most valuable publicity and promotion has come from enthusiastic people who actively sought us out.
  • Supporters often take serious time, and vet our work, before becoming highly enthusiastic.

Because of this, we have generally felt that improving the quality of our research, and our existing audience’s understanding of it, has been the most important factor in our growth. We’ve consistently seen our best results come from focusing not on “How can we get people to find out about us?” but “How can we get the people who have already sought us out, shown interest and found us to become as enthusiastic as possible?”

More detail follows. We first discuss approaches that have not worked particularly well, then discuss the major factors in the growth we’ve seen.

Approaches that have not worked particularly well

These approaches either (a) have not had strong return-on-investment in terms of money-moved-per-hour-of-staff-time-invested or (b) do not seem likely to yield significantly better results if we put in additional time.

  • Speaking opportunities. We’ve given a total of 50-100 talks – at companies (e.g., tech companies, banks, hedge funds, consulting firms), universities (undergrad, business and public health schools; both specific classes and broader community events), conferences, and smaller, personal events organized by GiveWell supporters. Few donors have found us via a talk. In hindsight, the costs of talks (e.g., practicing our talk, prepping slides, coordinating logistics, travel time) seem to have significantly outweighed the benefits. Over the past year or so, we’ve accepted invitations to speak, but only when (a) we can limit preparation time (e.g., by delivering our standard GiveWell talk rather than putting in serious preparation) and (b) travel time is low. We’ve also sometimes sent more junior staff to speak, partly for their training. Roughly speaking, I’d estimate that talks have yielded ~5-10 major supporters giving a total of approximately $200,000-$400,000/year. My best guess is that we have put in ~250-500 hours throughout our history into speaking opportunities.
  • Networking with people who haven’t shown proactive interest in GiveWell. We’ve conducted hundreds of 1-on-1 meetings or phone calls with prospective donors. As a general rule, when we’ve initiated the meeting (i.e., a supporter of ours suggested we meet someone or we asked a supporter of ours to make an introduction), we’ve very rarely converted that person into a fan. A common pattern is that someone thinks GiveWell is a “great idea” but that this recognition rarely results in action, e.g., giving to GiveWell or our top charities. (This was a topic of discussion at a July 2010 board meeting.) Networking of this type has yielded a few major donors who collectively give ~$100,000-$150,000/year.
  • Proactive media outreach. We’ve made various attempts to proactively encourage the media to cover us. We’ve had no notable success actively reaching out to the media; our media coverage has generally come via media reaching out to us. A fact that has further diminished our interest in allocating time to proactive media outreach is seeing the surprising (to us) results from what we would have considered major media. For example, we’ve seen limited returns – in terms of new donors – from appearances in newspapers like the Boston Globe and highly-trafficked major sites like Lifehacker, Reddit, and Gawker.
  • Google AdWords. We have run AdWords consistently since GiveWell began, and it has consistently been our best performing (in ROI terms) proactive outreach strategy. However, while it has had a strong return on money invested, we have not found a significant number of large donors via AdWords. In 2009 (the latest year for which we have the data), we spent approximately $650 on AdWords during the last week of the year and counted $5,310 donated, see our 2009 metrics report (DOC). In 2013, we ran significantly more AdWords as part of the Google Grants program, leading to 202 donors. (We are not currently tracking the amount given, though we hope to be able to do this in the near future.)

We have also tried other outreach approaches at various times. We have (a) cold-called family foundations and corporate giving departments to encourage them to use our recommendations; (b) retained a professional designer to prepare materials as takeaways from talks and 1-on-1 meetings; (c) evaluated PR firms as a means for gaining broader media exposure. Both (a) and (b) resulted in significant time spent with little-to-no results. When we spoke with PR firms in 2009 and 2012, we found that the media coverage they expected to be able to generate for us was comparable to the media coverage we had already had which had not led to strong results (i.e., many donors/major donors) in the past.

(For those particularly interested in our early attempts at outreach, see our 2008 change of direction writeup.)

GiveWell’s growth

While the approaches described above have not worked particularly well, GiveWell has grown significantly. Some highlights follow; more information is available in our annual and quarterly metrics reports.

Comparing our current reach to that which we had in December 2009 is instructive. By December 2009, we had already appeared in (a) a major New York Times article, (which also led to appearances on CNBC and NPR) and (b) Peter Singer’s book The Life You Can Save (which led to multiple additional media mentions during his book tour), and (c) Nick Kristof’s book, Half the Sky. Notwithstanding these major drivers of “eyeballs” to our website, GiveWell’s reach remained relatively limited.

Another interesting comparison is to our first December, in 2007, when we had an abnormal traffic spike due to being featured in an NYT story that reached #3 on the most-emailed articles list. We saw a total of ~50,000 visitors to our site that month – over 1/3 as many as in December 2013 – but our total money moved that month was only ~$30,000 (compare to more than $4.3 million in December 2013, excluding Good Ventures).

Our growth has been a function of audience enthusiasm and word-of-mouth, much more than of media exposure and attention.

How have donors found GiveWell?

We know the sources of our growth because we have surveyed and prioritized getting to know our major donors.

Most of our larger donors have told us that they either (a) found GiveWell while proactively looking for a resource to help them decide where to give or (b) heard about GiveWell from a trusted source (most commonly Peter Singer, other media, or a close friend or colleague).

Excluding Good Ventures (the single largest supporter of our top charities) and other institutions (which have different approaches to giving), over the past 3 years, 95 donors have accounted for close to 60% of the total non-institutional money GiveWell directed to top charities or received to support its operations. (Combining these two figures offers a reasonable picture of the most committed users/largest supporters of GiveWell’s work.)

We have data on how 84 of these 95 donors found us, which is shown in the table below:

How donor found GiveWell Number of donors Amount given (USD millions)
Proactive 22 $4.9
Peter Singer 21 $2.2
Personal 7 $1.6
New York Times 8 $1.1
Referral 11 $0.6
Marginal Revolution blog 6 $0.4
Other online 5 $0.4
Speaking opportunities 2 $0.2
Networking 2 $0.1
Total 84 $11.4

See this footnote for definitions and more technical discussion.

It is important to note that the success we’ve had when someone refers us (either via writing something or referring friends) has often been a function of specific individuals’ repeatedly and enthusiastically promoting us or discussing our work in public. This includes people in the media (or who frequently contribute in media) such as Peter Singer, Ken Stern, Nick Kristof, Alex Tabarrok and Stephanie Strom but also individuals like Jonah Sinick (who played a large role in introducing the LessWrong community to GiveWell) and Jeff Kaufman and Julia Wise (who have promoted GiveWell to their coworkers, friends and on their respective blogs). In general, we feel that high-enthusiasm, lower-profile promoters have benefited us far more than higher-profile, one-time endorsements.

Good Ventures

We excluded Good Ventures from the above discussion, but its story is important because it is the single largest donor to our top charities (having directed $12 million to those organizations over the past 3 years). Broadly speaking, Good Ventures came to GiveWell in the same way other major donors have. In a 2011 blog post, Cari Tuna, Good Ventures’ President, wrote, “I first learned about GiveWell about a year ago while preparing to transition from reporting to working in philanthropy full time. I read about the organization in Peter Singer’s The Life You Can Save and, around the same time, met co-founder Holden Karnofsky through a mutual friend. Right away, I was struck by the rigor of GiveWell’s research, its commitment to transparency and the volume of thoughtful commentary about the nonprofit sector it already had produced in just three years. In April 2011, I joined GiveWell’s board. Since then, I’ve been increasingly impressed by the co-founders’ dedication to their work, humility about what they know and what they don’t, and ability to adapt the GiveWell model as they learn.”

The importance of growing enthusiasm over time

After finding us, the first step most people take is, in one way or another, vetting the quality of our work. Some vet us intensively by reading the GiveWell website extremely carefully, following our blog, corresponding with us directly via email or phone, and participating in in-person research discussions (which we hold periodically in New York and San Francisco) before giving making a significant (for them) donation (i.e., giving the amount they eventually intend to give on an annual basis). Others decide to give significantly relatively soon after finding us (though in most cases report doing substantial vetting of our work before they do so).

We considered the donor patterns for our 50 largest donors (again excluding Good Ventures). We stopped at 50 solely in the interest of saving time and because as the dollar amounts fell, the overall picture was unlikely to change. We excluded 18 of these 50 donors because (a) we would guess that a change in donation size may have been driven by the fact that their first donation was early in GiveWell’s existence, and the change in donation size was likely a function of GiveWell’s growth rather than their comfort with our work, (b) gave so early that we don’t have easy access to their donation records, or (c) because 2013 was the first year in which they gave so we can’t yet know their “standard” donation size.Of the 32 remaining donors:

  • 16 donors representing $4.5 million made significantly larger (>2x) donations in subsequent years than they had in the first year they gave.
  • 8 donors representing $1.3 million followed us intensively for at least a year before making any donation.
  • 8 donors representing $1.1 million made first donations that were more than half the size of their subsequent donations.

Again, Good Ventures mirrors the pattern followed by our major retail donors. Cari and Dustin met us in February 2011. After that meeting, Cari and Dustin expressed an intention to make a $100,000 grant to support GiveWell, and Cari joined GiveWell’s board and followed GiveWell’s work closely. In December 2011, Good Ventures donated $750,000 to our top two charities at the time. In 2012, Good Ventures contributed $2 million to our top charities, and in 2013, Good Ventures contributed more than $9 million. The most important/successful media we’ve had has come from the same dynamic: i.e., people who learned about/found GiveWell and often took the time to follow us reasonably closely until they were confident in the quality of our work. Some other media has simply come via reporters’ using referrals to find us.

Our takeaways

Many of our supporters imagine that exposure is the main bottleneck to our growth – that our appeal speaks for itself, and that the most important challenge we face is making people aware that we exist. But the analysis above tells a different story: proactive outreach has generally done little for us, while strong relationships with enthusiastic supporters (which develop over a significant amount of time) have driven strong growth.We continue to pick “low-hanging fruit” when it comes to outreach, taking opportunities to gain exposure that require relatively little of our time and effort. However, the bulk of our energy goes into making our research as strong as possible and building relationships with the people who rely on it, and we believe this is the most important driver of our past and future growth.


Definitions:

  • Proactive – the donor told us that s/he was actively searching for a source like GiveWell at the time s/he found us.
  • Personal – the donor knew Elie or Holden personally before they started GiveWell.
  • New York Times – The New York Times has written about GiveWell many times; we have not tried to source donors to specific articles.
  • Referral – the donor told us that s/he found us from a friend or coworker who recommended GiveWell.
  • Other online – the donor told us that s/he found us online but we do not have the exact source or there was only 1 donor who found us via this source.
  • Speaking opportunities – the donor told us that s/he learned about GiveWell via a talk we gave.
  • Networking – we met the donor through general networking (i.e., asking people we knew to introduce us to people they know or people we knew making active introductions to their network).

Note that the sources we use for each donor are often not mutually exclusive. For example, many donors who proactively started looking for a source like GiveWell came across Peter Singer’s book, The Life You Can Save; others, had always intended to give significantly but had not started yet. Once they read Peter Singer’s book and learned about us, they started giving more. In the former case, we’ve catalogued the donor as “Proactive” and in the latter as “Peter Singer.” It is also true that Peter Singer has authored several articles in the New York Times and some donors may report either Peter Singer or New York Times if they found us via one of these articles. Peter Singer himself told us that he found GiveWell via our appearance in the New York Times Giving Section in November 2007, which we understand to have been caused by Times’ reporters finding and following our blog.

Against Malaria Foundation finalizes distribution agreement for ~676,000 nets

The Against Malaria Foundation (AMF) was our top-rated charity for approximately two years, before we suspended our recommendation last November for room for more funding related reasons.

We are happy to see that it has recently finalized an agreement to fund 676,000 nets – at a total cost of ~$2 million – in the Democratic Republic of Congo (DRC).

Our impression is that DRC is a very difficult country to work in; that said, our impression from speaking with AMF is that the agreement has met its high standards for monitoring and evaluation, and that we can expect strong reporting on this distribution. We will be following up and posting updates on the distribution’s progress.

We are not yet reinstating our recommendation of AMF, as it has still not committed the bulk of the funds it has available, but this is an important step forward – the largest single distribution AMF has finalized to date. AMF is still negotiating other potential distributions, and we are hopeful that it will commit the bulk of its funds and return to our top charities list.